Evidence map›Paper›PMID 24333843›Full record

ArticleProgress in neuro-psychopharmacology & biological psychiatry2014

Morphine-induced trafficking of a mu-opioid receptor interacting protein in rat locus coeruleus neurons.

Kellie M Jaremko, Nicholas L Thompson, Beverly A S Reyes, Jay Jin, Brittany Ebersole, Christopher B Jenney, Patricia S Grigson, Robert Levenson, Wade H Berrettini, Elisabeth J Van Bockstaele

Abstract read
In one paragraph

Article in Progress in neuro-psychopharmacology & biological psychiatry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Hypocretin/Orexin Interactions with Norepinephrine Contribute to the Opiate Withdrawal Syndrome.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2022
    Article
  2. Article
  3. Dopamine DNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2019
    Article
  4. Article
  5. Pentazocine Protects SN4741 Cells Against MPPFrontiers in aging neuroscience · 2017
    Article
  6. Addictive neurons.Therapeutic targets for neurological diseases · 2017
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Kellie M JaremkoDepartment of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, PA 19102, United States.
Nicholas L ThompsonDepartment of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, PA 19102, United States.
Beverly A S ReyesDepartment of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, PA 19102, United States. Electronic address: Beverly.Reyes@drexelmed.edu.
Jay JinDepartment of Pharmacology, Penn State College of Medicine, Hershey, PA 17033, United States.
Brittany EbersoleDepartment of Pharmacology, Penn State College of Medicine, Hershey, PA 17033, United States.
Christopher B JenneyDepartment of Neural and Behavioral Sciences, Penn State College of Medicine, Hershey, PA 17033, United States.
Patricia S GrigsonDepartment of Neural and Behavioral Sciences, Penn State College of Medicine, Hershey, PA 17033, United States.
Robert LevensonDepartment of Pharmacology, Penn State College of Medicine, Hershey, PA 17033, United States.
Wade H BerrettiniDepartment of Psychiatry, Center for Neurobiology and Behavior, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, United States.
Elisabeth J Van BockstaeleDepartment of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, PA 19102, United States.
Pennsylvania State University · USDrexel University · USUniversity of Pennsylvania · US

Funding

TREATMENT STRATEGIES FOR METHODONE NONRESPONDERSP60DA005186 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI O'BRIEN, CHARLES P · 1997 to 2012
$28.1M
OPIOID MODULATION OF THE COERULEO-CORTICAL PATHWAYR01DA009082 · NIDA · THOMAS JEFFERSON UNIVERSITY · PI VAN BOCKSTAELE, ELISABETH J · 2001 to 2017
$6.0M
Mu Opioid Receptor in AddictionP20DA025995 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI BERRETTINI, WADE H · 2008 to 2011
$3.4M
RESEARCH ON TREATMENT AND PREVENTION OF IV DRUG ABUSEP50DA005186 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI O'BRIEN, CHARLES A · 1987 to 1997
–
OPIOID MODULATION OF THE COERULEO-CORTICAL PATHWAYR29DA009082 · NIDA · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI VAN BOCKSTAELE, ELISABETH J · 1994 to 1998
–
NIDA NIH HHS DA 009082NIDA NIH HHS DA 05186NIDA NIH HHS P20 DA 025995NIDA NIH HHS P20 DA025995NIDA NIH HHS P60 DA005186NIDA NIH HHS R01 DA009082
6 · The paper itself

Abstract

Opiate addiction is a devastating health problem, with approximately 2million people currently addicted to heroin or non-medical prescription opiates in the United States alone. In neurons, adaptations in cell signaling cascades develop following opioid actions at the mu opioid receptor (MOR). A novel putative target for intervention involves interacting proteins that may regulate trafficking of MOR. Morphine has been shown to induce a re-distribution of a MOR-interacting protein Wntless (WLS, a transport molecule necessary for secretion of neurotrophic Wnt proteins), from cytoplasmic to membrane compartments in rat striatal neurons. Given its opiate-sensitivity and its well-characterized molecular and cellular adaptations to morphine exposure, we investigated the anatomical distribution of WLS and MOR in the rat locus coeruleus (LC)-norepinephrine (NE) system. Dual immunofluorescence microscopy was used to test the hypothesis that WLS is localized to noradrenergic neurons of the LC and that WLS and MOR co-exist in common LC somatodendritic processes, providing an anatomical substrate for their putative interactions. We also hypothesized that morphine would influence WLS distribution in the LC. Rats received saline, morphine or the opiate agonist [d-Ala2, N-Me-Phe4, Gly-ol5]-enkephalin (DAMGO), and tissue sections through the LC were processed for immunogold-silver detection of WLS and MOR. Statistical analysis showed a significant re-distribution of WLS to the plasma membrane following morphine treatment in addition to an increase in the proximity of gold-silver labels for MOR and WLS. Following DAMGO treatment, MOR and WLS were predominantly localized within the cytoplasmic compartment when compared to morphine and control. In a separate cohort of rats, brains were obtained from saline-treated or heroin self-administering male rats for pulldown co-immunoprecipitation studies. Results showed an increased association of WLS and MOR following heroin exposure. As the LC-NE system is important for cognition as well as decisions underlying substance abuse, adaptations in WLS trafficking and expression may play a role in modulating MOR function in the LC and contribute to the negative sequelae of opiate exposure on executive function.

Indexed as

Adrenergic NeuronsAnalgesics, OpioidAnimalsEnkephalin, Ala(2)-MePhe(4)-Gly(5)-HeroinInfusions, IntraventricularIntracellular Signaling Peptides and ProteinsLocus CoeruleusMaleMorphineNeuronsProtein BindingProtein TransportRatsReceptors, G-Protein-CoupledReceptors, Opioid, muAnalgesics, OpioidEnkephalin, Ala(2)-MePhe(4)-Gly(5)-HeroinIntracellular Signaling Peptides and ProteinsMorphineReceptors, G-Protein-CoupledReceptors, Opioid, muWls protein, ratConfocal microscopyElectron microscopyG-protein receptorNorepinephrineTraffickingWntless

Identifiers

PMID24333843
PMCPMC3928604
OpenAlexW2035343156

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.